These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Long-term steroid-immunosuppressive treatment of the childhood nephrotic syndrome. Pachioli R, Genova R. Pediatrics; 1971 Apr; 47(4):731-6. PubMed ID: 4326172 [No Abstract] [Full Text] [Related]
24. [Indications and limitations of immunosuppressive therapy in chronic glomerulonephritis]. Ponticelli C, Brancaccio D, Locatelli F, Imbasciati E. Minerva Nefrol; 1969 Apr; 16(3):228-34. PubMed ID: 5356052 [No Abstract] [Full Text] [Related]
25. Stability of remission in minimal lesion nephrotic syndrome after treatment with prednisolone and cyclophosphamide. Dundon S, O'Callaghan U, Raftery J. Int J Pediatr Nephrol; 1980 Mar; 1(1):22-5. PubMed ID: 7343524 [No Abstract] [Full Text] [Related]
27. Alkylating agents and purine analogues in primary glomerulonephritis with nephrotic syndrome. Ponticelli C, Passerini P. Nephrol Dial Transplant; 1991 Mar; 6(6):381-8. PubMed ID: 1876280 [No Abstract] [Full Text] [Related]
28. [Immunosuppressive treatment of glomerulonephritis and nephrotic syndrome]. Stojimirović B. Med Glas; 1971 Mar; 25(7):273-6. PubMed ID: 5148090 [No Abstract] [Full Text] [Related]
29. The idiopathic nephrotic syndrome of childhood. A clinical reevaluation of 148 cases. Makker SP, Heymann W. Am J Dis Child; 1974 Jun; 127(6):830-7. PubMed ID: 4834775 [No Abstract] [Full Text] [Related]
30. [Prognosis of the idiopathic nephrotic syndrome in childhood by means of plasma protein clearance]. Rossipal E. Wien Z Inn Med; 1969 Jun; 50(5):209-13. PubMed ID: 4982993 [No Abstract] [Full Text] [Related]
33. [Immunosuppresive agents in the treatment of nephropathies of children]. Schwalbová M, Krajci-Lazáryová M, Misíková Z. Bratisl Lek Listy; 1969 Feb; 51(2):198-205. PubMed ID: 5779177 [No Abstract] [Full Text] [Related]
34. [Correlations between the histological changes and results of treatment with corticoids and immunosuppressive agents in primary glomerulonephritis]. Lagrue G, Bariety J. Minerva Med; 1970 Jul 11; 61(55):3054-63. PubMed ID: 5427678 [No Abstract] [Full Text] [Related]
35. Cytotoxic drugs in steroid-resistant renal disease. Alkylating and antimetabolic agents in the treatment of nephrotic syndrome, lupus nephritis, chronic glomerulonephritis, and purpura nephritis in children. Grupe WE, Heymann W. Am J Dis Child; 1966 Nov 11; 112(5):448-58. PubMed ID: 5917978 [No Abstract] [Full Text] [Related]
36. An in vitro steroid sensitivity test: antibody-dependent cellular cytotoxicity (ADCC) reaction of peripheral lymphocytes in children with nephrotic syndrome. Petri I, László A, Bodrogi T. Acta Paediatr Hung; 1985 Nov 11; 26(3):247-53. PubMed ID: 4084413 [Abstract] [Full Text] [Related]
38. [Primary corticosteroid-resistant nephrotic syndrome in pediatrics]. Tuya CO, Muñoz M, Costa JA, Repetto HA. Medicina (B Aires); 1984 Nov 11; 44(1):1-7. PubMed ID: 6535901 [No Abstract] [Full Text] [Related]
39. The familial nephrotic syndrome. I. A European survey. White RH. Clin Nephrol; 1973 Nov 11; 1(4):215-9. PubMed ID: 4783718 [No Abstract] [Full Text] [Related]
40. Combined prednisolone, azathioprine, and cyclophosphamide treatment for persistent proliferative glomerulonephritis in adults. Mukherjee AP. Lancet; 1971 Dec 18; 2(7738):1350-3. PubMed ID: 4108267 [No Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]